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Linear	and	non-linear	eGFR	slopes	in	ADPKD	patients	reaching	ESRD	
	
Letter	to	the	Editor,	AJKD	Re:	Brosnahan	et	al,	AJKD	2017	
	
Dear	Sir		
	
We	read	with	interest	this	paper	reporting	patients	from	the	HALT-PKD	trials	
with	non-linear	eGFR	slopes	and	non-progressors	as	defined	by	serial	eGFR	1.	
Although	these	results	are	interesting,	it	is	uncertain	how	they	relate	to	the	
entire	course	of	disease	or	long-term	clinical	outcomes	in	unselected	non-trial	
populations.	
	
We	performed	a	retrospective	analysis	of	individual	eGFR	slopes	in	an	
unselected	ADPKD	patient	group	reaching	end-stage	renal	disease	(ESRD)	at	our	
centre	over	four	decades	(1978-2016).	To	capture	changes	over	a	longer	period,	
we	restricted	analysis	to	patients	with	a	minimum	of	10	years	available	annual	
eGFR-EPI	measurements	prior	to	ESRD,	dividing	them	into	two	groups	based	on	
their	initial	eGFR:	Group	A	(>100ml/min/1.73m2;	n=12)	and	Group	B	
(<100ml/min/1.73m2;	n=25).	Data	from	eGFR	slopes	were	fitted	to	linear	or	
non-linear	models	of	eGFR	decline.	
	
The	majority	of	patients	in	both	groups	had	a	linear	decline	in	eGFR	with	a	
higher	percentage	in	Group	B.	However	a	significant	number	in	both	groups	(25-
36%)	showed	a	more	complex	pattern.	Examples	of	each	are	shown	in	Figure	1.	
In	conclusion,	a	linear	decline	in	eGFR	was	observed	in	the	majority	of	patients	
with	ADPKD	reaching	ESRD.	However	deviations	from	linearity	(unrelated	to	
acute	events)	occurred	in	a	significant	proportion	of	patients	and	may	be	
informative	for	clinical	management,	future	trial	design	and	mechanistic	studies.	
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